Trials
Search / Trial NCT06429085

Rex Robot Assisted Rehabilitation to Enhance Balance and Mobility for People With Multiple Sclerosis, Clinical and Biomarker Study - RAPPER IV

Launched by EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST · May 20, 2024

Trial Information

Current as of February 08, 2025

Completed

Keywords

Balance Core Stability Mobility Powered Exoskeleton Neuro Rehabilitation

ClinConnect Summary

The key research questions:

* Is it feasible for a person with balance and mobility impairment caused by MS to use a robotic walking device to exercise in standing and walking with supervision safely?
* What are the key outcome measures most sensitive to measurable change in this study population sample, which may reflect potential improvement during the trial period? (Clinical outcome scales and self-reported questionnaires)
* Is this robotic assisted balance and mobility training program feasible, safe and effective?
* Does the completion of this balance and mobility exercise treatment i...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Are aged greater than 18 years and less than 80 years
  • Have a confirmed diagnosis of MS by a Consultant Neurologist as per McDonald Criteria.
  • Have moderate mobility restriction as defined by an Extended Disability Status Scale (EDSS) score of between 4 to 6.5
  • Ten participants to be recruited from EDSS 4 to 5.5
  • Ten participants to be recruited from EDSS 5.5 to 6.5
  • Within the anthropometric requirements of the REX device (See 'RAPPER III- MS 014 TF-04 v 3.0 REX Clinical Assessment Guide A4' for details of weight, height, size and range of motion requirements)
  • Offer written informed consent to take part in the study
  • Exclusion Criteria:
  • a history of osteoporosis or osteoporosis related bone fractures.
  • skin integrity issues that could be adversely affected by the REX device
  • severe hypertonia (spasticity) as indicated by a score equal to or greater than 4 on the modified Ashworth scale for any muscle in their lower limbs.
  • a behavioural, cognitive or communication impairment which could interfere with the ability to participate in a rehabilitation program, as noted during screening (e.g., agitation, inability to follow two step commands)
  • are unable or unwilling to provide informed consent
  • are considered medically unsuitable for rehabilitation in the opinion of the screening medical specialist
  • a known allergy (skin contact) to materials used in Rex
  • are pregnant
  • taking part in any other medical research trial at the same time

About East Kent Hospitals University Nhs Foundation Trust

East Kent Hospitals University NHS Foundation Trust is a leading healthcare provider in the southeast of England, dedicated to delivering high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence and innovation, the Trust operates multiple hospitals and community services, facilitating a wide range of clinical trials across various specialties. Committed to enhancing patient outcomes, the Trust collaborates with academic institutions and industry partners to translate research findings into practice, ensuring that cutting-edge therapies and treatments are accessible to the communities it serves.

Locations

Canterbury, Kent, United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0